VIB organizes the 4th edition of Applied Bioinformatics in Life Sciences

On March 10-11, the 4th edition of Applied Bioinformatics in Life Sciences will take place in the Provinciehuis in Leuven, Belgium.

Bioinformatics has quickly become an integral part of life sciences research by enabling innovative computational approaches in an increasingly data-dense environment. Inspired by the sold-out editions in 2016, 2018, and 2020, VIB is organizing this fourth edition to highlight recent developments in bioinformatics research and to showcase its impact on medical, agricultural, and biotechnological research.

Alex Botzki, Head of the VIB Informatics Core, launched this VIB Bioinformatics series in 2016:

‘I am happy to see the Applied Bioinformatics conference series evolve over the past years by following latest developments in computational biology which set the scene for more and more breakthroughs in modern data-intensive life sciences research.’

The conference has attracted many internationally renowned speakers. Anna Kreshuk (Cell Biology and Biophysics, EMBL Heidelberg, DE) will open the session on Image analysis. Smita Krishnaswamy (Yale School of Medicine, US) ​ will focus on deep representation learning methods that are applied to a variety of datasets from cancer biology, immunology, … In the session ‘Proteomics and metabolomics’ Niko Beerenwinkel (ETH, Zurich, CH) will present ‘Computational analysis of tumor single-cell sequencing data’. ‘Integrative analysis of multi-omics data’ is the research topic of Britta Velten (German Cancer Research Center (DKFZ), DE & Wellcome Sanger Institute, UK).

In addition to the plenary presentations, 70 young researchers will present their work during one of the poster sessions. Over 200 people will join the conference live or virtually.

More info

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be